ArticleMolecular biotechnology2025

Co-delivery of Liposomal Ketoconazole and Bevacizumab for Synergistical Inhibition of Angiogenesis Against Endometrial Cancer.

Shanshan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.